|
COMMERCE BUSINESS DAILY ISSUE OF DECEMBER 7,1998 PSA#2236National Cancer Institute, Research Contracts Branch, ESS, Executive
Plaza South, Rm. 620, 6120 Executive Blvd., MSC 7224, Bethesda, MD
20892-7224 B -- INTERDISCIPLINARY STUDIES OF GENETIC AND ENVIRONMENTAL CAUSES OF
CANCER SOL N02-CP-91026-50 DUE 012599 POC Karen L. McFarlane,
Contracting Officer, (301) 496-8611 WEB: Acquisition Management Branch
Home Page, http://amb.nci.nih.gov/rfp.htm. E-MAIL: Karen L. McFarlane,
km63k@nih.gov. ELECTRONIC RFP ANNOUNCEMENT, POTENTIAL OFFERORS WILL BE
RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND
AMENDMENTS. The Genetic Epidemiology Branch (GEB) of the National
Cancer Institute is re-competing a contract for support for
interdisciplinary studies, NO2-CP-60534, currently held by Westat, Inc.
The contract will establish a mechanism to provide all the services
required to conduct a wide variety of domestic and international family
studies and field (case-control and cohort) studies. Although the
scientific design and oversight of the activities are the
responsibility of the Genetic Epidemiology Branch professional staff,
the major activities of the contract provide: 1) nursing support
including contacting family members, explaining the studies, enrolling
family members, obtaining clinical information and records, requesting
pathology slides for diagnosis confirmation, arranging for family
members to be evaluated by GEB investigators in the Cancer Genetics
Clinic at the Clinical Center, performing phlebotomy, obtaining other
biologic specimens as necessary, arranging and conducting field trips
to evaluate family members,verifying information for the family
registry database, maintaining tracking systems for data and biologic
specimens, developing and providing educational materials for
participants, and participating in genetic counseling and risk
notification; 2) maintenance of a locked medical record room to which
GEB investigators have immediate access; 3) development of coordination
and liaison at a local or international level with collaborating
investigators or institutions whose cooperation is needed for the
conduct of a study; 4) assistance in the design and pilot testing of
forms required for field investigations (e.g., questionnaires,
abstracting forms, coding forms, manuals for field procedures and other
documents); 5) hiring, training and supervision of field personnel
(interviewers, abstractors, and others); 6) identification of study
subjects, including locating cancer patients and/or their relatives,
selection of controls through such methods as random digit dialing and
acquisition of appropriate study population rosters or files; 7)
supervision and management of field operations; 8) collections of data
(interviewing/record abstraction, biologic specimen collection and
processing); 9) data reduction activities (coding, keying, and editing)
of data collected into a format suitable for computer analysis; 10)
quality control and standardization so that appropriate and valid data
result. The maintenance of a secure record room which allows GEB
investigators access to the medical records within 15 minutes is a
mandatory requirement. There is also a mandatory requirement of the
capability of nearly daily face to face meetings with the GEB staff.
The anticipated solcitation issue date is approximately 21 days after
publication of this notice, and proposals will be sue approximately 30
days after the issue date. The RFP may be accessed through the
Acquisition Management Branch Home Page by using the following Internet
address: http://amb.nci.nih.gov/rfp.htm. IT IS THE OFFERORS
RESPONSIBILITY TO MONITOR THE ABOVE INTERNET SITE FOR THE RELEASE OF
THE SOLICITATION AND ANY AMENDMENTS. All responsible sources may submit
a proposal which shall be considered by the NCI. Point of Contact is
Karen L. McFarlane; electronic mail address: km63k@nih.gov; fax
301-480-0241. No collect calls will be accepted. (0027) Posted 12/03/98
(W-SN276683). (0337) Loren Data Corp. http://www.ld.com (SYN# 0008 19981207\B-0001.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|